Allena Pharmaceuticals [ALNA] - Last Close: $0.133
Allena Pharmaceuticals is on our list again as the stock's rally continues.
The biotech stock closed yesterday's session with a 70.5% gain, but the gains didn't stop at the closing bell.
For the second day in a row, the stock is surging despite no major news. The registered direct offering announced last week remains the most recent press release of note.
Despite the lack of an obvious catalyst, Allena surged into the after-hours trading session, and it's up again in today's premarket.
ALNA is one of this morning's most active stocks, and it's up 21.1%.
Calithera Biosciences [CALA] - Last Close: $0.1611
Shares of Calithera Biosciences are rallying ahead of the opening bell.
The clinical-stage biopharma firm reported its Q1 financial results and highlights after Tuesday's closing bell, and the report didn't get a warm reception in the markets.
Calithera fell from $0.2047 per share to $0.1600 per share following the after-hours earnings release on Tuesday.
The report also prompted a downgrade from Wells Fargo, which lowered its price target on the stock from $3 to $2 but maintained its rating of "equal-weight."
CALA is rebounding from its rough run in today's premarket. The stock is up 44.6% on active trading volume.
